
Estriol Unconjugated









The Estriol Unconjugated test is a blood test used to measure the levels of the unconjugated estriol, a hormone produced by the placenta during pregnancy. It helps assess the well-being of the fetus and monitor pregnancy health.













Understanding Estriol Unconjugated
The Estriol Unconjugated test is often done as a part of the triple or quadruple screening test conducted during the second trimester of pregnancy. This test analyzes a specific marker called unconjugated estriol (uE3), a form of estrogen produced by the fetoplacental unit during pregnancy.Estriol plays an important role in maintaining pregnancy by supporting the growth and development of the unborn child.
By measuring the levels of unconjugated estriol, doctors can assess the unborn child's well-being and the overall pregnancy. Abnormal levels of unconjugated estriol, done as part of the pre-natal screening tests may indicate certain fetal abnormalities or complications, such as Down syndrome (trisomy 21), trisomy 18, or other chromosomal abnormalities. Timely detection of these abnormalities is vital for ensuring comprehensive prenatal care and addressing potential health problems effectively.
The Estriol Unconjugated test is a screening test, and any abnormal result does not necessarily mean that the unborn baby has a birth defect or genetic condition. It only tells whether the unborn baby is at risk of developing certain abnormalities, and further testing is required to confirm the diagnosis. The decision to recommend the Estriol Unconjugated test is often based on maternal age, medical history, and individual risk factors for chromosomal abnormalities. Pregnant women should consult their doctor to determine the most appropriate screening or diagnostic test based on their specific conditions.
No special preparation is required before undergoing a Estriol Unconjugated test. However, a woman needs to be prepared to provide informed consent before undertaking this test. The laboratory personnel will explain the purpose, benefits, and limitations of this test.
Abnormal lab test results represent only the risk but not the diagnostic outcomes. Increased risk does not mean that the baby is affected, and further tests must be performed before a confirmed diagnosis can be made. Talk to the doctor about the specific test results. The results of the Estriol Unconjugated test, along with a woman's clinical symptoms and other factors, can help doctors detect and manage pregnancy-related abnormalities and make informed decisions regarding further testing or interventions.
What does Estriol Unconjugated measure?
The Estriol Unconjugated test is used to assess the level of unconjugated estriol (uE3) in the blood, a specific type of estrogen produced during the pregnancy phase. This hormone is mainly synthesized in the placenta and the fetus, with the fetus being responsible for a substantial amount of uE3 production as it grows.
Monitoring the uE3 levels in the maternal serum is useful in evaluating the condition of the fetus. Abnormal unconjugated estriol levels may indicate pregnancy-related complications or concerns, including chromosomal abnormalities, fetal distress, or placental problems. The Estriol Unconjugated is particularly crucial in the second trimester to assess for some conditions, such as Down syndrome, Edward syndrome, or other chromosomal abnormalities, fetal growth and development. Hence the estriol unconjugated test is a significant part of prenatal care as it reveals information that may be valuable for the diagnosis and management of the mother and the baby.





FAQs related to Estriol Unconjugated
- David M, Merksamer R, Israel N, Dar H. Unconjugated estriol as maternal serum marker for the detection of Down syndrome pregnancies. Fetal Diagn Ther. 1996 Mar-Apr;11(2):99-105. [Accessed 09 Dec. 2024]. Available from:
- Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Canick JA, Haddow JE, Knight GJ, Palomaki GE. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol. 1988 Apr;95(4):334-41. [Accessed 09 Dec. 2024]. Available from:
- Minsart AF, Van Onderbergen A, Jacques F, Kurt C, Gillerot Y. Indication of prenatal diagnosis in pregnancies complicated by undetectable second-trimester maternal serum estriol levels. J Prenat Med. 2008 Jul;2(3):27-30. PMID: 22439024; PMCID: PMC3279090. [Accessed 09 Dec. 2024]. Available from:
- Sablok A, Sharma A, Ahmed CS, Kaul A. Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience. Indian J Med Res. 2021 May;154(5):716-722. [Accessed 09 Dec. 2024]. Available from:
- Gordon S, Umandap C, Langaker MD. Prenatal Genetic Screening. [Updated 2023 Jan 16]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
- Güdücü N, Görmüş U, Güner Eİ, Güzel O, Kavak ZN. Quadruple test parameters in art pregnancies. Int J Clin Exp Med. 2014 Aug 15;7(8):2319-23. PMID: 25232428; PMCID: PMC4161588. [Accessed 09 Dec. 2024]. Available from:
Other tests
- CBC (Complete Blood Count)
- FBS (Fasting Blood Sugar)
- Thyroid Profile Total (T3, T4 & TSH)
- HbA1c (Glycosylated Hemoglobin)
- PPBS (Postprandial Blood Sugar)
- Lipid Profile
- Vitamin D (25-Hydroxy)
- Urine R/M (Urine Routine & Microscopy)
- Coronavirus Covid -19 test- RT PCR
- LFT (Liver Function Test)
- KFT (Kidney Function Test)
- TSH (Thyroid Stimulating Hormone) Ultrasensitive
- ESR (Erythrocyte Sedimentation Rate)
- Uric Acid, Serum
- Vitamin B12
- CRP (C-Reactive Protein), Quantitative
- Urine C/S (Urine Culture and Sensitivity)
- Serum Electrolytes
- Serum Calcium
- Serum Creatinine
- Diabetes Screening (HbA1C & Fasting Sugar)
- KFT with Electrolytes (Kidney Function Test with Electrolytes)
- Cholesterol - Total
- Hb (Hemoglobin)
- Complete Hemogram (CBC & ESR)





















